345 related articles for article (PubMed ID: 7524376)
21. Metastatic uveal melanoma. A morphologic and immunohistochemical analysis.
Luyten GP; Mooy CM; Post J; Jensen OA; Luider TM; de Jong PT
Cancer; 1996 Nov; 78(9):1967-71. PubMed ID: 8909318
[TBL] [Abstract][Full Text] [Related]
22. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemistry in the differential diagnosis of nodular hidradenoma and glomus tumor.
Haupt HM; Stern JB; Berlin SJ
Am J Dermatopathol; 1992 Aug; 14(4):310-4. PubMed ID: 1380207
[TBL] [Abstract][Full Text] [Related]
24. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
25. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
[TBL] [Abstract][Full Text] [Related]
26. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
[TBL] [Abstract][Full Text] [Related]
27. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
Mirecka J; Korabiowska M; Schauer A
Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
[TBL] [Abstract][Full Text] [Related]
28. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
[TBL] [Abstract][Full Text] [Related]
29. A comparative immunohistochemical study of adenoid cystic carcinoma of the skin and salivary glands.
Bergman R; Lichtig C; Moscona RA; Friedman-Birnbaum R
Am J Dermatopathol; 1991 Apr; 13(2):162-8. PubMed ID: 1709341
[TBL] [Abstract][Full Text] [Related]
30. An immunohistochemical study of mixed tumor of the skin.
Mohri S; Andoh S
J Dermatol; 1991 Jul; 18(7):414-9. PubMed ID: 1724253
[TBL] [Abstract][Full Text] [Related]
31. Microcystic adnexal carcinoma. An immunohistochemical comparison with other cutaneous appendage tumors.
Wick MR; Cooper PH; Swanson PE; Kaye VN; Sun TT
Arch Dermatol; 1990 Feb; 126(2):189-94. PubMed ID: 1689137
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemistry of eccrine poroma and porocarcinoma--more than acrosyringeal tumors?
Wollina U; Castelli E; Rülke D
Recent Results Cancer Res; 1995; 139():303-16. PubMed ID: 7541147
[TBL] [Abstract][Full Text] [Related]
33. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
[TBL] [Abstract][Full Text] [Related]
34. Anorectal malignant melanoma. A clinicopathologic study, including immunohistochemistry and DNA flow cytometry.
Ben-Izhak O; Levy R; Weill S; Groisman G; Cohen H; Stajerman S; Misselevich I; Nitecky S; Eidelman S; Kerner H
Cancer; 1997 Jan; 79(1):18-25. PubMed ID: 8988722
[TBL] [Abstract][Full Text] [Related]
35. S100, HMB-45, and Melan-A negative primary melanoma.
Shinohara MM; Deubner H; Argenyi ZB
Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
[TBL] [Abstract][Full Text] [Related]
36. Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumor: report of 16 cases.
King R; Busam K; Rosai J
Am J Surg Pathol; 1999 Dec; 23(12):1499-505. PubMed ID: 10584703
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
Heegaard S; Jensen OA; Prause JU
Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
[TBL] [Abstract][Full Text] [Related]
38. Expression of various antigens by different components of uterine mixed müllerian tumors. An immunohistochemical study.
Chung MT; Mukai K; Teshima S; Kishi K; Shimosato Y
Acta Pathol Jpn; 1988 Jan; 38(1):35-45. PubMed ID: 2452553
[TBL] [Abstract][Full Text] [Related]
39. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
[TBL] [Abstract][Full Text] [Related]
40. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.
Fuchs U; Kivelä T; Summanen P; Immonen I; Tarkkanen A
Am J Pathol; 1992 Jul; 141(1):169-81. PubMed ID: 1378696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
